Information regarding the specific cost of a quetiapine manufacturing plant is not publicly available. The expenses involved in establishing such a facility are highly variable, depending on numerous factors.
What influences the cost of building a pharmaceutical manufacturing plant?
The total investment for a pharmaceutical manufacturing plant is determined by scale, location, technology, and regulatory compliance [1]. Key cost drivers include land acquisition, construction materials, specialized equipment for drug synthesis and formulation, cleanroom facilities, quality control laboratories, warehousing, and utility infrastructure [1]. Regulatory requirements for Good Manufacturing Practices (GMP) also add significant costs related to validation, documentation, and environmental controls [1].
How do patent expirations affect manufacturing plant investments?
When a drug's patent expires, it opens the door for generic manufacturers to enter the market [2]. This can lead to increased demand for manufacturing capacity for the now off-patent drug, potentially spurring investment in new plants or expansion of existing ones by generic companies [2]. Conversely, for the originator company, the reduced profitability after patent expiry might influence decisions about future capital investments in manufacturing related to that specific drug [2].
When does patent exclusivity for quetiapine end?
Quetiapine is marketed under the brand name Seroquel. Information on the specific patent expiry dates for quetiapine can be found on resources like DrugPatentWatch.com [3]. Generally, once patents expire, generic versions of the drug can be developed and manufactured.
What are the typical costs associated with generic drug manufacturing?
The cost of manufacturing generic drugs is generally lower than for branded drugs due to factors like scaled production, simplified research and development, and competitive market pricing [4]. Generic manufacturers aim to optimize production processes and supply chains to achieve cost efficiencies [4]. For a drug like quetiapine, once off-patent, multiple generic manufacturers may compete, driving down prices and influencing the economic viability of their manufacturing operations [4].